Medicine

Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction

Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.

1987.6.1JOURNAL OF CRITICAL CARE

DOI: 10.1016/0883-9441(87)90149-3

tlooto Summary

SK seems to be a safe drug for routine administration in acute myocardial infarction in patients admitted within 12 h after the onset of symptoms and with no contraindications to SK when randomised to receive SK in addition to usual treatment.

Abstract

Abstract is not available.

Citation format

MIOCARDICO., Gruppo Italiano per lo Studio della Soprawivenza nell'Inf. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. JOURNAL OF CRITICAL CARE, 1987, 2: 144.